About Exelixis
Exelixis is an oncology-focused biopharmaceutical company based in Alameda, California, that discovers, develops, and commercializes cancer treatments. Its lead product is cabozantinib, marketed under the brand names Cabometyx and Cometriq. The company trades on the Nasdaq stock exchange under the ticker symbol EXEL.
Active Jobs at Exelixis
0 jobs found
Upgrade to see 37 additional jobsNo active jobs right now. Check back soon or browse all jobs.
Benefits at Exelixis
401(k)401(k) MatchingBonusDental InsuranceFlexible HoursFlexible Spending Account (FSA)Health InsuranceLife InsuranceMedical InsurancePaid Time OffProfessional DevelopmentSick LeaveStock OptionsTraining BudgetVacation DaysVision Insurance